Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis. A clinico-pathologic study

Photodermatology Photoimmunology and Photomedicine

Volumn 20, Issue 3, 2004, Pages 148-156

  El Mofty, M ^a   Mostafa, W ^a   El Darouty, M ^a   Bosseila, M ^a   Nada, H ^a   Yousef, R ^a   Esmat, S ^a   El Lawindy, M ^a   Assaf, M ^b   El Enani, G ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Low dose UVA histopathology; Morphea; Morphometry; Systemic sclerosis

Indexed keywords

COLLAGEN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; FEMALE; HISTOPATHOLOGY; HUMAN; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MALE; MORPHEA; MORPHOMETRICS; PATHOGENESIS; PHOTOTHERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PUVA; SCHOOL CHILD; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIATION DOSAGE; SCLERODERMA, LOCALIZED; SCLEROSIS; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 2942571905     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2004.00081.x     Document Type: Article

References (31)

1. Jaworsky C. Connective tissue diseases. In: Elder D, Elenitsas R, Jaworsky C, Johnson B Jr, eds. Lever's histopathology of the skin, 8th edn. Philadelphia: Lippincott-Raven Publishers, 1997; 253-285.
2. Rosenwasser T, Eisen A. Scleroderma. In: Fitzpatrick TB, Eisen A, Wolff K, Freedberg I, Austen K, eds. Dermatology in general medicine, 4th edn. New York: McGraw-Hill Book Company, 1993; 2156-2167.
3. Le Roy E. Increased collagen synthesis by scleroderma skin fibroblasts in vitro. J Clin Invest 1979; 54: 880-889.
4. Takeda K, Hatamochi A, Ueki H, Nakata M, Oishi Y. Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 1994; 103: 359-363.
5. von Kobyletzki G, Uhle A, Pieck C, Hoffmann K, Altmeyer P. Acrosclerosis in patients with systemic sclerosis responds to low dose UV-A1 phototherapy. Arch Dermatol 2000; 136: 275-276.
6. Morita A, Sakakibara S, Sakakibara N, Yamauchi R, Tsuji T. Successful treatment of systemic sclerosis with topical PUVA. J Rheumatol 1995; 22: 2361-2365.
7. Rowell N, Goodfield M. The connective tissue diseases. In: Champion R, Burton J, Burnser D, Breathnach S, eds. Textbook of dermatology, 6th edn. Oxford: Blackwell Scientific, 1998; 2437-2576.
8. Fleischmajer R. Localized and systemic scleroderma. In: Lapiere CM, Krieg T, eds. Connective tissue diseases of the skin. New York: Marcel Dekker, 1993; 295-313.
9. Rook A, Freundlich B, Jegasothy B, et al. Treatment of systemic sclerosis with extracorporal photochemotherapy. Arch Dermatol 1992; 128: 337-346.
10. Cribier B, Faradji T, Le Coz C, Oberling F, Grosshans E. Extracorporeal photochemotherapy in systemic sclerosis and severe morphea. Dermatology 1995; 191: 25-31.
11. Kerscher M, Volkenandt M, Meurer M, Lehmann P, Plewig G, Rocken M. Treatment of localized scleroderma with PUVA bath photochemotherapy. Lancet 1994; 343: 1233.
12. Scharffetter-Kochanek K, Goldermann R, Lehmann P, Holzle E, Goerz G. PUVA therapy in disabling pansclerotic morphea of children. Br J Dermatol 1995; 132: 830-831.
13. Grundmann-Kollmann M. PUVA-cream photochemotherapy for the treatment of localized scleroderma. J Am. Acad Dermatol 2000; 43: 675-678.
14. Stege H, Berneburg M, Humke S, et al. High dose UVA-1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997; 36: 938-944.
15. Kerscher M, Volkenandt M, Gruss C, et al. Low dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998; 38: 21-26.
16. Morita A, Kobayashi K, Isomura I, Tsuji T, Krutmann J. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol 2000; 43: 670-674.
17. El-Mofty M, Zaher H, Bosseila M, Yousef R, Saad B. Low-dose broad-band UVA in morphea using a new method for evaluation. Photodermatol Photoimmunol Photomed 2000; 16: 43-49.
18. Grewe M, Gyufko K, Krutmann J. Interleukin-10 production by cultured human keratinocytes, regulation by UVA radiation. J Invest Dermatol 1995; 104: 3-6.
19. Grabbe J, Welker P, Humke S, et al. High dose UVA-1 but not UVA/UVB therapy decreases IgE binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol 1996; 107: 419-422.
20. Stege H, Schopf E, Ruzicka T, Krutmann J. High dose UVA-1 for urticaria pigmentosa. Lancet 1996; 347: 64.
21. Krutmann J. UVA-1 radiation induced immunomodulation, UVA-1 for atopic dermatitis. In: Krutmann J, Elmets C, eds. Photoimmunology. Oxford: Blackwell Scientific, 1995; 246-256.
22. Scharffetter K, Wlaschek M, Hogg A, et al. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 1991; 283: 506-511.
23. Fitzpatrick TB. Soleil et Peau. J Med Esthet 1975; 2: 33.
24. Wlaschek M, Briviba R, Stricklin G, Sies H, Scharffetter-Kochanek K. Singlet oxygen may mediate the ultraviolet-A induced synthesis of interstitial collagenase. J Invest Dermatol 1995; 104: 194-198.
25. Wlaschek M, Heinen G, Poswing A, Schwarz A, Krieg T, Scharfetter-Kochanek K. Interrelated autocrine loops of IL-1 and IL-6 stimulates the synthesis of collagenase/MMP-1 after UVA irradiation. Photochem Photobiol 1994; 5: 550-556.
26. Brenneisen P, Briviba K, Wlaschek M, Wenk J, Scharfetter-Kochanek K. Hydrogen peroxide increases the steady state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts. Free Radical Biol Med 1997; 22: 515-524.
27. Kiss M, Wlaschek M, Brenneisen P, et al. Alpha-melanocyte stimulating hormone induces collagenase/matrix metalloproteinase-16 in human dermal fibroblasts. Biol Chem Hoppe Seyler 1995; 376: 425-429.
28. De Rie M, Bos J. Photochemotherapy for systemic and localized scleroderma. J Am Acad Dermatol 2000; 43: 725-726.
29. Steger J, Matthews J. UVA therapy for scleroderma. J Am Acad Dermatol 1999; 40: 787-788.
30. Gruss C, von Kobyletzki G, Behrens S, et al. Effects of low dose ultraviolet A-1 phototherapy on morphea. Photodermatol Photoimmunol Photomed 2001; 17: 149-155.
31. Ghoreschi K, Roecken M. Efficacy of photochemotherapy and UVA-1 therapy in patients with morphea or lichen sclerosus. Photodermatol Photoimmunol Photomed 2002; 18: 104-104.